Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Chronic inflammatory activation of arterial endothelial cells in mice under normal lipoprotein/cholesterol levels and on normal diet.

ABSTRACT: Chronic inflammatory activation of arterial endothelial cells in mice under normal lipoprotein/cholesterol levels and on normal diet.

PROVIDER: PRJNA961776 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR24301787.fastq.gz	Fastqsanger.gz
	SRR24301788.fastq.gz	Fastqsanger.gz
	SRR24301789.fastq.gz	Fastqsanger.gz
	SRR24301790.fastq.gz	Fastqsanger.gz
	SRR24301791.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 8

Similar Datasets

Chronic inflammatory activation of arterial endothelial cells in mice under normal lipoprotein/cholesterol levels and on normal diet.

Project description:Inflammatory activation of endothelial cells is considered to be the first step in the development of atherosclerosis. Here, we determined changes of aortic gene expression after chronic inflammatory activation of arterial endothelial cells in genetically modified mice.

2024-05-07 | GSE230566 | GEO

Effect of lipoprotein(a) on Arterial Endothelial Cells

Project description:Human Arterial Endothelial Cells (HAECs; Lonza) were incubated with either 5mg/dl or 100mg/dl isolated lipoprotein(a) for 6 hours. Next, RNA was isolated (RIN>9) and processed for NGS. NGS details: Sequencing of RNA (rRNA depleted), HiSeq4000, Paired-End, 150 bp

2020-05-26 | GSE145898 | GEO

Effect of lipoprotein(a) on Arterial Endothelial Cells

Project description:Effect of lipoprotein(a) on Arterial Endothelial Cells

| PRJNA608696 | ENA

Peturbation of PICALM Levels Alters Cellular Cholesterol Metabolism

Project description:PICALM (Phosphatidyl Inositol Clathrin Assembly Lymphoid Myeloid protein) is a ubiquitously expressed protein that plays a role in clathrin-mediated endocytosis. PICALM also affects the internalization of SNAREs and modulates macroautophagy. Chromosomal translocations that result in the fusion of PICALM to heterologous proteins cause leukemias, and genome-wide association studies have linked Single Nucleotide Polymorphisms (SNPs) of PICALM to Alzheimer’s disease. To obtain insight into the biological role of PICALM, we performed gene expression studies of PICALM-deficient and PICALM-expressing cells. Pathway analysis demonstrated that PICALM expression influences the expression of genes that encode proteins involved in cholesterol biosynthesis and lipoprotein uptake. GC-MS studies indicated that loss of PICALM increases total cholesterol pool size. Isotopic labeling studies revealed that loss of PICALM alters cholesterol homeostasis via increased scavenging of cholesterol. Measurement of LDL receptor endocytosis further showed that PICALM deficient cells express higher LDLR levels resulting in higher lipoprotein internalization. These findings suggest that PICALM is required for cellular cholesterol homeostasis and point to a novel mechanism by which PICALM alterations may contribute to disease. Total RNA was isolated (Qiagen RNeasy® Micro kit, Valencia, CA) from four replicates of PICALM knockout cells transfected with control vector, and from four replicates of PICALM knockout cells transfected with PICALM.

2015-06-17 | E-GEOD-64855 | biostudies-arrayexpress

Sex-specific KDM6A-HNF4A-CREBH network controls lipoprotein cholesterol metabolism and atherosclerosis via epigenetic reprograming of hepatocytes

Project description:The liver is a central organ controlling lipid and cholesterol metabolism and plays a key role in regulating lipoprotein profiles and cardiovascular disease risk. Males and females show clear differences in cholesterol handling and susceptibility to atherosclerosis, but the molecular basis for these sex-specific effects remains incompletely understood. Here we show that the X-linked histone demethylase 6A (KDM6A) is essential for maintaining healthy cholesterol metabolism in the liver. Reducing KDM6A levels in human liver cells disrupts gene programs involved in lipoprotein regulation linked to cardiovascular disorders. Consistently, female mice lacking KDM6A specifically in hepatocytes develops pro-atherogenic blood lipoprotein profiles and increased atherosclerosis under genetic and dietary stress, whereas males are largely unaffected. Mechanistically, KDM6A cooperates with Hepatocyte Nuclear Factor 4 Alpha (HNF4A) to promote chromatin activation and enable CREBH (encoded by CREB3L3)-dependent transcription of lipid metabolic genes. These findings identify KDM6A as a sex-linked regulator of hepatic cholesterol metabolism.

2026-02-19 | GSE287736 | GEO

Peturbation of PICALM Levels Alters Cellular Cholesterol Metabolism

2015-06-17 | GSE64855 | GEO

Sex-specific KDM6A-HNF4A-CREBH network controls lipoprotein cholesterol metabolism and atherosclerosis via epigenetic reprograming of hepatocytes [RNA-seq]

2026-02-19 | GSE287688 | GEO

Sex-specific KDM6A-HNF4A-CREBH network controls lipoprotein cholesterol metabolism and atherosclerosis via epigenetic reprograming of hepatocytes [CUT&Tag]

2026-02-19 | GSE287680 | GEO

RNA-Seq of rabbits treated with normal diet or high cholesterol diet

Project description:We fed PGC1-alpha (mouse gene) transgenic rabbits and control rabits with normal diet or high cholesterol diet. Then we extract RNA from their vascular cells and performed RNA-Seq comapre the expression level of the mRNAs.

2021-06-08 | GSE176340 | GEO

The Microbiota Promotes Arterial Thrombosis in Low-Density Lipoprotein Receptor-Deficient Mice

Project description:The Microbiota Promotes Arterial Thrombosis in Low-Density Lipoprotein Receptor-Deficient Mice

| PRJEB29436 | ENA